The Ministry of Food and Drug Safety has published updated Good Manufacturing Practice (GMP) evaluation guidelines for pharmaceuticals, outlining assessment procedures, standards, and administrative processes.

Key Updates:

  • Expanded Scope: Broader principles, methods, and review standards for compliance assessment.
  • Evaluation Process: Includes document reviews, on-site investigations, and assessment periods.
  • Submission Requirements: 11 types of required data, including manufacturing floor plans, facility management records, and environmental controls.
  • Non-Face-to-Face Inspections: Conducted via video conferencing, lasting 4 to 8 hours per day, with 2–3 GMP inspectors.
  • These guidelines ensure pharmaceutical manufacturing meets strict quality and safety standards.

Region: East Asia

Source: https://www.mfds.go.kr/brd/m_1059/view.do?seq=15140&srchFr=&srchTo=&srchWord=&srchTp=&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=1

pattern
pattern
Got questions? We’ve got answers!

Let's talk Regulatory!

Reach out to us and let’s unravel your Regulatory puzzle together. Unlock regulatory solutions with our global subject matter experts and tap into a wealth of regulatory intelligence.

Speak to an Expert